Development of NGS–Based Workflows for CQAs for Product Characterization in CGT
From Science to Compliance: Building Trusted NGS-Based GMP Assays
Genedata Selector: Accelerate the Path to GxP for Sequencing-Based Assays
Accelerating Preparative Chromatography Workflows Through Smarter Data Analysis
Analytical Chromatography Workflow Automation at Novartis
HILIC MS-enabled sMAM: Advancing the Future of Biotherapeutic Characterization
Simplifying Deep Antibody Mining for Maximum Impact
Unified Platform for Automated Developability Assessment and AI-Driven Predictive Modeling
Leveraging Genedata Screener for Biophysical Developability Assessment in Discovery Biologics Screening
Mass Spec Data Digital Transformation at Lilly Biologics Discovery
How Challenges in Biologics Development Catalyze Innovations in Cell Line Development
Japan: Thinking Plasma Biomarkers for Alzheimer’s Disease End-to-End
Unlocking NGS and Regulatory Synergy in GCT for Maximum Impact
NGS for Product Characterization in CGT: Biosafety and Genome Integrity
From Science to Compliance: Effective Validation of Genedata Selector
Discover What’s New in Genedata Screener 2026
Japan: Cutting Days from the DMTA Cycle in Discovery Research
Genedata Selector Product Development Roadmap
Japan: Driving Next-Generation Discovery with Organoids
Japan: Increasing Efficiency of Antibody Discovery and Engineering Workflows
Japan: Utilizing Genedata Biologics’ Versatility for Cloud Software Integrations
Therapeutic Antibody Profiling with Genedata Biologics — AI & ML Framework for Cancer Drug Discovery
Towards MAM in QC: Accelerating Adoption with Streamlined Data Analysis Strategies
Merck: Accelerating Precision Medicine: Using AI Assistants in GxP Environments
Exploring an AI-Native Approach to Antibody Discovery
Lessons Learned from a Global Genedata Deployment: Impact on Automation, Novel Modalities, and AI/ML
Image Analysis with Machine Learning (ML) at Arvinas
Data, Data in the Well: Who’s the FAIRest of them all? A Tale of In Vitro Characterization of Biologics Preparing for the AI Era
Japan: Enterprise Analytics Platform for Biopharma Mass Spectrometry
Japan: Integrated Data Management for Multi-Modality Drug Development
Rapid Contamination Identification with Nanopore Sequencing
Automating Adventitious Agent Detection for GMP and Lot Release
Merck: Automating the DMTA Cycle for Faster Drug Discovery
Powering HT Protein Expression and Purification
A Multiplexed Platform for Covalent Ligand Screening
Democratizing NGS Analysis for Cell Line Development
Japan: Biopharma Discovery DX
Integrating Wet & Digital Labs to Accelerate Biologics Discovery
Fireside Chat: RNA Therapeutics & Data Innovation
